MedPath

Acarbose

Acarbose Tablets

Approved
Approval ID

a474a365-d93a-4c6e-a479-0004b7ac4d2c

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 6, 2023

Manufacturers
FDA

A-S Medication Solutions

DUNS: 830016429

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

acarbose

PRODUCT DETAILS

NDC Product Code50090-4952
Application NumberANDA090912
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateJuly 27, 2022
Generic Nameacarbose

INGREDIENTS (5)

MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
ACARBOSEActive
Quantity: 50 mg in 1 1
Code: T58MSI464G
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Acarbose - FDA Drug Approval Details